Intralesional excision as a surgical strategy to manage keloid scars: what's the evidence?
- PMID: 31565400
- PMCID: PMC6755860
- DOI: 10.1177/2059513119867297
Intralesional excision as a surgical strategy to manage keloid scars: what's the evidence?
Abstract
Introduction: Keloid scars are a particularly challenging clinical entity and a variety of management approaches have been described in the literature including intralesional surgery. The current literature lacks a summative review to ascertain the evidence base behind this surgical approach.
Methods: A comprehensive English literature database search was performed using PubMed Medline, EMBASE and Web of Science from their individual dates of inception to March 2018. We present the different rationales proposed for the use of this technique, the clinical outcomes reported in the literature as well as the scientific basis for intralesional excision of keloid scars.
Discussion: A number of arguments have been proposed to support intralesional excision including avoiding injury to neighbouring non-keloidal skin and the deep layer of the dermis, removal of the most proliferative fibroblastic group as well as debulking to facilitate the administration of injectable steroid. The most current literature does not provide sufficient support for the adoption of intralesional excisions based on data emerging from basic science as well as clinical outcome studies.
Conclusion: Emerging evidence supports the extralesional excision of keloid scars based on current mechanobiological, histological as well as clinical outcome data. Further trials comparing extralesional and intralesional surgical practices are eagerly awaited to ascertain the role of intralesional excisions in the keloid management arena.
Keywords: Intralesional; extralesional; hypertrophic; intramarginal; keloid; scar.
© The Author(s) 2019.
Conflict of interest statement
Declaration of conflicting interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Concomitant therapy of surgical shave excision and intralesional injections for ear keloids: Early results from a retrospective cohort study.Scars Burn Heal. 2022 May 11;8:20595131221098531. doi: 10.1177/20595131221098531. eCollection 2022 Jan-Dec. Scars Burn Heal. 2022. PMID: 35572361 Free PMC article.
-
The use of botulinum toxin in keloid scar management: a literature review.Scars Burn Heal. 2020 Jun 26;6:2059513120926628. doi: 10.1177/2059513120926628. eCollection 2020 Jan-Dec. Scars Burn Heal. 2020. PMID: 32637157 Free PMC article. Review.
-
Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management.Nig Q J Hosp Med. 2007 Oct-Dec;17(4):134-9. doi: 10.4314/nqjhm.v17i4.12693. Nig Q J Hosp Med. 2007. PMID: 18320758 Review.
-
Intralesional excision with topical intralesional cryotherapy improves the treatment of keloid scarring in a paediatric patient.Ann R Coll Surg Engl. 2017 Nov;99(8):e233-e335. doi: 10.1308/rcsann.2017.0156. Epub 2017 Sep 15. Ann R Coll Surg Engl. 2017. PMID: 29022793 Free PMC article.
-
Hypertrophic and keloid scars fail to progress from the CD34- /α-smooth muscle actin (α-SMA)+ immature scar phenotype and show gradient differences in α-SMA and p16 expression.Br J Dermatol. 2020 Apr;182(4):974-986. doi: 10.1111/bjd.18219. Epub 2019 Sep 4. Br J Dermatol. 2020. PMID: 31206605
Cited by
-
The clinical efficacy of single-hole punch excision combined with intralesional steroid injection for nodular keloid treatment: a self-controlled trial.Sci Rep. 2024 Apr 29;14(1):9793. doi: 10.1038/s41598-024-60670-x. Sci Rep. 2024. PMID: 38684804 Free PMC article.
-
Multi-stage surgery combined with radiotherapy for treatment of giant anterior chest wall keloid: A case report.Medicine (Baltimore). 2020 Jan;99(4):e18886. doi: 10.1097/MD.0000000000018886. Medicine (Baltimore). 2020. PMID: 31977896 Free PMC article.
-
Concomitant therapy of surgical shave excision and intralesional injections for ear keloids: Early results from a retrospective cohort study.Scars Burn Heal. 2022 May 11;8:20595131221098531. doi: 10.1177/20595131221098531. eCollection 2022 Jan-Dec. Scars Burn Heal. 2022. PMID: 35572361 Free PMC article.
-
Management of Spontaneous and Pruritic Keloids: A Case Report.Cureus. 2022 Mar 16;14(3):e23227. doi: 10.7759/cureus.23227. eCollection 2022 Mar. Cureus. 2022. PMID: 35449684 Free PMC article.
-
Keloid Intralesional Excision Reduces Recurrence: A Meta-analytic Study of the Available Literature on 608 Keloids.Plast Reconstr Surg Glob Open. 2024 Mar 8;12(3):e5652. doi: 10.1097/GOX.0000000000005652. eCollection 2024 Mar. Plast Reconstr Surg Glob Open. 2024. PMID: 38463702 Free PMC article.
References
-
- Luo S, Benathan M, Raffoul Wet al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001; 107: 87–96. - PubMed
-
- Huang C, Liu L, You Zet al. Endothelial dysfunction and mechanobiology in pathological cutaneous scarring: lessons learned from soft tissue fibrosis. Br J Dermatol 2017; 177(5): 1248–1255. - PubMed
-
- Hochman B, Locali RF, Matsuoka PKet al. Intralesional triamcinolone acetonide for keloid treatment: a systematic review. Aesthetic Plast Surg 2008; 32(4): 705–709. - PubMed
Publication types
LinkOut - more resources
Full Text Sources